Prosecution Insights
Last updated: October 02, 2026
Application No. 15/367,356

COMPOSITION FOR HAIR FRIZZ REDUCTION

Non-Final OA §103§DOUBLEPATENT
Filed
Dec 02, 2016
Priority
Dec 04, 2015 — provisional 62/263,152
Examiner
VANHORN, ABIGAIL LOUISE
Art Unit
1636
Tech Center
1600 — Biotechnology & Organic Chemistry
Assignee
The Procter & Gamble Company
OA Round
11 (Non-Final)
47%
Grant Probability
Moderate
11-12
OA Rounds
0m
Est. Remaining
69%
With Interview

Examiner Intelligence

Grants 47% of resolved cases
47%
Career Allowance Rate
570 granted / 1219 resolved
-13.2% vs TC avg
Strong +22% interview lift
Without
With
+22.4%
Interview Lift
resolved cases with interview
Typical timeline
3y 9m
Avg Prosecution
74 currently pending
Career history
1295
Total Applications
across all art units

Statute-Specific Performance

§101
1.6%
-38.4% vs TC avg
§103
41.9%
+1.9% vs TC avg
§102
8.5%
-31.5% vs TC avg
§112
24.0%
-16.0% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1219 resolved cases

Office Action

§103 §DOUBLEPATENT
DETAILED ACTION Receipt of Arguments/Remarks filed on June 14 2024 is acknowledged. Claims 4, 13-14 and 19-21 were/stand cancelled. Claim 12 was amended. Claims 1-3, 5-12, 15-18 and 22 are pending. Claims 5-11 are withdrawn from further consideration pursuant to 37 CFR 1.142(b) as being drawn to a nonelected invention, there being no allowable generic or linking claim. Election was made without traverse in the reply filed on September 27 2017. Claims 1-3, 12, 15-18 and 22 are directed to the elected invention. Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Withdrawn Objection The amendment filed June 14 2024 is sufficient to overcome the objection of claim 12. The recitations 5-chlorosalicylic acid and 2-hexyl-1-decanol have been removed from the claim. Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102 of this title, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. The factual inquiries set forth in Graham v. John Deere Co., 383 U.S. 1, 148 USPQ 459 (1966), that are applied for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. This application currently names joint inventors. In considering patentability of the claims the examiner presumes that the subject matter of the various claims was commonly owned as of the effective filing date of the claimed invention(s) absent any evidence to the contrary. Applicant is advised of the obligation under 37 CFR 1.56 to point out the inventor and effective filing dates of each claim that was not commonly owned as of the effective filing date of the later invention in order for the examiner to consider the applicability of 35 U.S.C. 102(b)(2)(C) for any potential 35 U.S.C. 102(a)(2) prior art against the later invention. Claims 1-3, 15-18 and 22 are rejected under 35 U.S.C. 103 as being unpatentable over Allef et al. (US PGPUB No. 20140349902, cited in the Office action mailed on 1/30/18) in view of Bernard et al. (USPGPUB No. 20070014748, cited in the Office action mailed on 6/12/19), Moller et al. (US Patent No. 4496536, cited in the Office action mailed on 1/30/18) and Taylor et al. (USPGPUB No. 20080138438, cited in the Office action mailed on 1/30/18) and as evidenced by Benvenuti (futurederm.com, 2011, cited in the Office action mailed on 1/4/19) and Anderson et al. (USPGPUB No. 20090104136, cited in the Office action mailed on November 13 2019). Applicant Claims The instant application claims a shampoo composition comprising from about 0.2 to about 8% of a moisture control material which is oleic acid wherein the shampoo composition further comprises from about 0.5 to about 2% of salicylic acid, from about 2 to about 10% of 2-hydroxyethyl urea and propylene glycol and wherein there is a decrease moisture pickup determined by a DVS method as compared to a control with no moisture control materials and further comprising 5-chlorosalicylic acid and 2-hexyl-1-decanol. The examiner interprets the further comprising language to be further limiting the shampoo composition claimed as comprising 5-chlorosalicylic acid and 2-hexyl-1-decanol. The instant application claims method of treating hair using the shampoo composition of Claim 1 wherein hair treated with the shampoo composition results in a decrease moisture pickup determined by a DVS method as compared to a control with no moisture control materials. Determination of the Scope and Content of the Prior Art (MPEP §2141.01) Allef et al. is directed to aqueous hair and skin cleaning compositions comprising biosurfactants. Table 24 is a shampoo comprising water (solvent) in an amount greater than 20%, oleic acid in 0.4%, cocamidopropyl betaine (cationic surfactant in 2% reading on instant claim 18), propylene glycol and citric acid to adjust pH to 5.0 (reading on instant claims 15-16). Table 25 teaches a shampoo comprising water in greater than 20%, oleic acid in 0.15%, propylene glycol, glycol distearate in 1% and cocamidopropyl betaine in 2.5 (reading on cationic surfactant of claim 18). Gels are taught (claim 15). The fatty acid is included in amounts from 0.1 to 20% by weight of the sum of fatty acid and surfactants where surfactants are used in an amounts from 1 to 30% (claim 1). Fatty acids taught include valeric acid and oleic acid (paragraph 0029). Exemplified compositions include oleic acid and salicylic acid and propylene glycol (table 41, 66, 77, 82, reading on the claimed combination of oleic acid, salicylic acid and propylene glycol recited in claim 1). Exemplified amounts of salicylic acid include 2% (table 66). The compositions can also comprise urea (paragraph 0046). Ascertainment of the Difference Between Scope the Prior Art and the Claims (MPEP §2141.012) Allef et al. does not teach compositions comprising 2-hydroxyethyl urea. However, this deficiency is cured by Bernard et al. Bernard et al. is directed to urea compounds that promote desquamation. Taught is a method for stimulating desquamation of the skin and/or the mucous membranes and/or superficial body growths comprising apply to skin or superficial body growths urea compounds of formula I (claim 1). Claim 6 recites a compound of formula I is N-(2-hydroxyethyl)urea. Application to the skin and/or scalp is claimed (claim 12). Taught is combination of two desquamation-stimulating agents the compound of formula I and salicylic acid (paragraph 0223). The quantity of N-(2-hydroxyethyl)urea and of any other compound of formula I is from 0.1 to 20% by weight. Less than or equal to 10% by weight is particular for daily care applications (paragraph 0038). Compositions taught include shampoos (paragraph 0073). Benvenuti teaches that Pequi oil which is mostly oleic acid is better for frizzy hair. Allef et al. does not teach the inclusion of 5-chlorosalicylic acid or 2-hexyl-1-decanol. However, these deficiencies are cured by Moller et al. and Taylor et al. Moller et al. is directed to sebosuppressive cosmetic preparations containing long-chained alkanols and antioxidants. Taught are topical cosmetic preparations useful in the treatment of seborrhea and strongly oily hair. The compositions comprise alkanols such as 2-hexyldecanol (column 1, lines 45-59 and claim 2). Shampoo is exemplified (example 1). Hexadecanol is exemplified (table sample 8 and 15). Taylor et al. is directed to compositions having high antiviral and antibacterial efficacy. Taught are personal care products incorporating an active antimicrobial agent (paragraph 0067). Taught are the inclusion of organic acids to control the pH. Acids taught include 5-chlorosalicylic acid (paragraphs 0118-0123). The pH taught is 5 or less. Finding of Prima Facie Obviousness Rationale and Motivation (MPEP §2142-2143) It would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to combine the teachings of Allef et al., Bernard et al., Moller et al. and Taylor et al. and utilize 2-hydroxyethyl urea in the invention of Allef et al. in order to provide for desquamation as taught by Bernard et al. One of ordinary skill in the art would have a reasonable expectation of success as the urea compounds of Bernard et al. are taught to be used in shampoos and with other desquamation agents such as salicylic acid and Allef et al. teaches the compositions can comprise urea. It would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to combine the teachings of Allef et al., Bernard et al., Moller et al. and Taylor et al. and use the shampoo composition to treat hair. One of ordinary skill in the art would have been motivated to utilize shampoo with hair as that is the design of a shampoo. Although the reference is silent about the moisture pickup, it does not appear that the claim language or limitations result in a manipulative difference in the method steps when compared to the prior art disclosure. See Bristol-Myers Squibb Company v. Ben Venue Laboratories, 58 USPQ2d 1508 (CAFC 2001). “It is a general rule that merely discovering and claiming a new benefit of an old process cannot render the process again patentable.” In re Woodruff, 16 USPQ2d 1934, 1936 (Fed. Cir. 1990). Granting a patent on the discovery of an unknown but inherent function would remove from the public that which is in the public domain by virtue of its inclusion in, or obviousness from, the prior art. In re Baxter Travenol Labs, 21 USPQ2d 1281 (Fed. Cir. 1991). See M.P.E.P. 2145. On this record, it is reasonable to conclude that the same subject is being administered the same active agent by the same mode of administration in the same amount in both the instant claims and the prior art reference. The fact that Applicant may have discovered yet another beneficial effect from the method set forth in the prior art does not mean that they are entitled to receive a patent on that method. Finally, as evidenced by Benvenuti oleic acid is known to be useful in treating frizzy or brittle hair. As evidenced by Anderson et al., moisture on hair and its penetration into the hair can disturb the arrangement of hair proteins, resulting in cosmetically undesired changes such as, an increase in frizz. Moisture resistance refers to the hysteresis of water sorption/desorption when measured by DVS. In DVS a sample is placed on a microbalance exposed to a continuous flow of air with a predetermined and constant relative humidity. As the humid air passes over the sample, a zone of constant moisture concentration is created around it. Mass changes in the sample due to water vapor sorption/desorption can be measured between different levels of relative humidity at a particular temperature (paragraphs 0289-0290). Taught is a 4% reduction in the average hysteresis values compared to control (paragraph 0298). Examples include oleic acid (paragraphs 0362-0364). This is more evidence to a reasonable expectation in treating the hair with the composition of Allef et al. which contains examples with the instantly claimed moisture control material would possess the instantly claimed decrease in moisture pickup. It would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to combine the teachings of Allef et al., Bernard et al., Moller et al. and Taylor et al. and utilize 2-hexyldecanol in the composition of Allef et al. One of ordinary skill in the art would have been motivated to utilize 2-hexyldecanol in order to treat seborrhea as taught by Moller et al. One of ordinary skill in the art would have a reasonable expectation of success as Moller et al. teaches the use of these compounds in a shampoo. It would have been obvious to one of ordinary skill in the art to try any of the specifically taught alcohols as a person with ordinary skill has good reason to pursue known options within his or her technical grasp. Note: MPEP 2141 KSR International CO. v. Teleflex Inc. 82 USPQ 2d 1385 (Supreme Court 2007). It would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to combine the teachings of Allef et al., Bernard et al., Moller et al. and Taylor et al. and utilize 5-chlorosalicylic acid to manipulate the pH. Since Allef et al. exemplify the use of acids to control the pH, there is a reasonable expectation of success in utilizing the 5-chlorosalicylic acid. It would have been obvious to one of ordinary skill in the art to try any known acid pH modifiers as a person with ordinary skill has good reason to pursue known options within his or her technical grasp. Note: MPEP 2141 KSR International CO. v. Teleflex Inc. 82 USPQ 2d 1385 (Supreme Court 2007). One skilled in the art would have a reasonable expectation of success as Taylor et al. teaches 5-chlorosalicylic acid to manipulate the pH to 5 or less and this pH is similar to the pH taught in Allef et al. Regarding the claimed amount of salicyclic acid, Allef et al. exemplify an amount reading on the claims. Regarding the claimed amount of oleic acid, Allef et al. teaches an overlapping amount. Regarding the claimed amount of 2-hydroxyethyl urea, Bernard et al. teaches an overlapping amount. In the case where the claimed ranges "overlap or lie inside ranges disclosed by the prior art" a prima facie case of obviousness exists. See MPEP 2144.05. Regarding the claimed for hair frizz reduction, this is the intended use of the composition. A recitation of the intended use of the claimed invention must result in a structural difference between the claimed invention and the prior art in order to patentably distinguish the claimed invention from the prior art. If the prior art structure is capable of performing the intended use, then it meets the claim. Note: MPEP 2111.02. Since Allef et al. exemplify a composition comprising the same claimed moisture control material in an overlapping amount, it is capable of performing the intended use. Claims 1-3, 12, 15-18 and 22 are rejected under 35 U.S.C. 103 as being unpatentable over Allef et al. in view of Bernard et al., Moller et al., and Taylor et al. as applied to claims 1-3, 15-18 and 22 above and in further view of Khoshdel et al. (USPGPUB No. 20050175567, cited on PTO Form 1449) Applicant Claims The instant application claims the composition further comprises 2,4-dihydrobenzoic acid. Determination of the Scope and Content of the Prior Art (MPEP §2141.01) The teachings of Allef et al., Bernard et al., Moller et al. and Taylor et al. are set forth above. Ascertainment of the Difference Between Scope the Prior Art and the Claims (MPEP §2141.012) Allef et al. does not teach the inclusion of 2,4-dihydrobenzoic acid. However, this deficiency is cured by Khoshdel et al. Khoshdel et al. is directed to hair care compositions containing phenolic styling agents. Taught are hair care treatment compositions comprising a styling compound of formula 1: PNG media_image1.png 187 227 media_image1.png Greyscale . A preferred composition is where n is 0 and R2-R6 is H or OH (paragraph 0020). R1 includes H or OH (paragraph 0007). Compositions of the invention include shampoos (paragraph 0026). The compound provides improved hold to the hair (paragraph 0017). Conditioner compositions additionally comprise fatty materials. The combined use of fatty materials and cationic surfactants is believed to be especially advantageous because this leads to the formation of a structured phase in which the cationic surfactant is dispersed. Fatty material includes fatty alcohol, an alkoxylated fatty alcohol, a fatty acid or a mixture thereof. Concentration of fatty material is from 0.01 to 15% (paragraph 0113-0119). Finding of Prima Facie Obviousness Rationale and Motivation (MPEP §2142-2143) It would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to combine the teachings of Allef et al., Bernard et al., Moller et al., Taylor et al. and Khoshdel et al. and utilize the styling compounds of Khoshdel et al. in the composition of Allef et al. One of ordinary skill in the art would have been motivated to add the styling compounds in order to improve hold to the hair as taught by Khoshdel et al. One of ordinary skill in the art would have a reasonable expectation of success as Khoshdel et al. teaches the compounds can be utilized in a shampoo. Response to Arguments Applicants’ arguments filed June 14 2024 have been fully considered but they are not persuasive. Applicants argue that (1) Allef et al., Bernard et al., Moller et al. and Taylor et al. as evidenced by Benvenuti and Anderson al. do not disclose the instantly claimed composition provide the results of the present invention. It is argued that the combination of reference do not disclose or would lead one of skill in the art to the results found on page 43 in Table 5. This example is directed to a leave on treatment composition that contains 2% of 2-hydroxyethyl urea which increases the penetration of salicyclic acid inside the hair by 14% compared to the corresponding composition that does not contain 2-hydroxyethyl urea (see example XXVII and XXVIII). One skilled in the art would not be motivated to combine the cited reference in the hope of arriving at the present invention’s results compared to a composition that does not contain 2-hydroxyethyl urea. It is argued that claim 1 requires that the claimed components provide wherein there is a decrease in moisture pickup determined by a DVS method compared to a control with no moisture control materials. The Office Action states that although the reference is silent it does not appear that the claim language or limitations result in a manipulative difference in the method steps. Applicants assert that decrease moisture pick is not inherent as supported by the data discussed above. It is argued that all of the Office Actions added explanation of DVIS is unrelated to the present invention claimed decrease moisture pickup and no evidence in Allef or any other cited reference would lead one of skill in the art to determine, without undue experimentation that the present invention would result in decreased moisture pickup. The Office Action asserts that it provides motivation but this is just a conclusory statement. It is argued that the cited prior art provides no identified reason that would have prompted a person of ordinary skill in the relevant field to specifically select from about 0.2 to about 8% of a moisture control material wherein the shampoo composition further comprises from about 0.5 to about 2% of salicylic acid, from about 2 to about 10% hydroxyethyl urea, propylene glycol, 5-chlorosalicyclic acid, 2-hyexyl-1-deconol and wherein there is a decrease moisture pickup determined by a dynamic vapor sorption compared to a control with no moisture control materials. Regarding Applicants’ first arguments, the examiner has previously responded to these arguments and the board has indicated that these arguments are not persuasive in the decision mailed on July 26 2023. The prior art need not suggest the combination of the claimed ingredients for the same reason that Applicants have combined the references (see pages 5-6 of the board decision). Regarding the data in the specification, these results are equally not persuasive (see pages 6-7 of the board decision). The examiner notes that a leave on treatment composition isn’t a shampoo. But even if it were, this composition does NOT include oleic acid which is the required moisture control material. Therefore, the results are not commensurate in scope with the claims. Therefore, whether or not the prior art suggests that 2-hydroxyethyl urea can enhance the penetration of salicylic acid is immaterial for comparison as it does not contain the required oleic acid. The only examples that contain oleic acid are V and VII (page 35 of the instant specification) or G and I (page 31 of the instant specification). While I includes oleic acid and salicylic acid, 2-hexyldecanol, it does not contain 5-chlorosalicyclic acid and 2-hydroxyethyl urea. While I has a higher % water reduction vs. control, so do examples C and H. It does not appear that even when taking into account the combination of ingredients which are claimed that the result in I is anything more than additive. While Applicants are of the position that the examiner has made conclusory statements. This is not correct, the examiner has provided reasons as to why one skilled in the art would include each of the claimed ingredients, see also the board decision pages 10-11. As repeatedly pointed out by the board, the law does NOT require that the ordinary artisan combine the teachings in the art for the same reasons that prompted the claimed composition. KSR Inti Co. v. Teleflex Inc., 550 U.S. at 419; In re Beattie, 974 F.2d at 1312; Catalina Mktg., 289 F.3d at 809; In re Lintner, 458 F.2d at 1016. The recitation “for hair frizz reduction” is an intended use. A recitation of the intended use of the claimed invention must result in a structural difference between the claimed invention and the prior art in order to patentably distinguish the claimed invention from the prior art. If the prior art structure is capable of performing the intended use, then it meets the claim. Here, nothing in the arguments establish a structural difference between the claimed invention and prior art that distinguishes the claimed invention. In fact, Allef et al. exemplifies composition with the same moisture control agent, i.e. oleic acid, in the same claimed amount. Regarding the other limitation, “wherein there is a decrease moisture pickup determined by a dynamic vapor sorption (DVS) method as compared to a control with no moisture control materials”. This is referring to comparing a composition comprising oleic acid, i.e. the moisture control agent claimed, and a composition without oleic acid. As indicated above, Allef et al. exemplifies a composition with oleic acid in the same claimed amount. Therefore, this recitation cannot distinguish the instant claims from the cited prior art. Applicants argue that (2) there is no identified reason that would have prompted a person of ordinary skill to select the combination of 5-chlorosalicylic acid and 2-hexyl-1-decanol. Treating oily hair, improving hair hold or manipulating pH has nothing to do with the present invention. This is a conclusory statement. The Office Action cannot selectively pick-and-choose various components from the encyclopedic disclosure found in the cited documents and reassemble them unerringly to arrive at the present invention. This is hindsight reconstruction. Regarding Applicants’ second argument, again, It is well settled that "any need or problem known in the field of endeavor at the time of invention and addressed by the patent can provide a reason for combining the elements in the manner claimed." KSR Int 'l Co. v. Teleflex Inc., 550 U.S. 398, 420 (2007). As long as some suggestion to combine the elements is provided by the prior art as a whole, the law does not require that they be combined for the reason or advantage contemplated by the inventor. In re Beattie, 974 F.2d 1309, 1312 (Fed. Cir. 1992); In re Kronig, 539 F.2d 1300, 1304 (CCPA 1976). MPEP 2143.01 and 2144 (IV). The reason or motivation to modify the reference may often suggest what the inventor has done, but for a different purpose or to solve a different problem. It is not necessary that the prior art suggest the combination to achieve the same advantage or result discovered by applicant. See, e.g., In re Kahn, 441 F.3d 977, 987, 78 USPQ2d 1329, 1336 (Fed. Cir. 2006) (motivation question arises in the context of the general problem confronting the inventor rather than the specific problem solved by the invention); Cross Med. Prods., Inc. v. Medtronic Sofamor Danek, Inc., 424 F.3d 1293, 1323, 76 USPQ2d 1662, 1685 (Fed. Cir. 2005) ("One of ordinary skill in the art need not see the identical problem addressed in a prior art reference to be motivated to apply its teachings."); In re Lintner, 458 F.2d 1013, 173 USPQ 560 (CCPA 1972) (discussed below); In re Dillon, 919 F.2d 688, 16 USPQ2d 1897 (Fed. Cir. 1990), cert. denied, 500 U.S. 904 (1991) In In re Lintner, the claimed invention was a laundry composition consisting essentially of a dispersant, cationic fabric softener, sugar, sequestering phosphate, and brightener in specified proportions. The claims were rejected over the combination of a primary reference which taught all the claim limitations except for the presence of sugar, and secondary references which taught the addition of sugar as a filler or weighting agent in compositions containing cationic fabric softeners. Appellant argued that in the claimed invention, the sugar is responsible for the compatibility of the cationic softener with the other detergent components. The court sustained the rejection, stating "The fact that appellant uses sugar for a different purpose does not alter the conclusion that its use in a prior art composition would be [sic, would have been] prima facie obvious from the purpose disclosed in the references." 173 USPQ at 562. This is also supported in the board decision mailed on July 26 2023, see pages 5-6 of the decision. As long as there is motivation provided to add the claimed ingredients the rejection is proper. As established in the Office action above, one skilled in the art would add 2-hydroxyethyl urea to provide for desquamation as taught by Bernard et al. One skilled in the art would have been motivated to utilize 2-hexyldecanol in order to treat seborrhea as taught by Moller et al. One skilled in the art would have been motivated to utilize 5-chlorosalicylic acid to manipulate the pH as taught by Taylor et al. Since Allef et al. teaches the use of acids to manipulate there is a reasonable expectation of success. Therefore, the examiner cannot agree that the rejection is based on hindsight. Applicants continue argue that the prior art would not be motivated to add the claimed ingredients in order to improve efficacy for % water reduction and % frizz reduction. However, there is absolutely no requirement that the prior art teach the inclusion of these ingredients for this purpose. There must be some motivation to include these ingredients, the examiner agrees with this, but there is no requirement that the reason to included the claimed components is for the same purpose as applicants. As established above, the cited prior art provides the motivation to include the claimed ingredients. While the prior art might teach various ingredients, they are all taught for a particular function and it would have been obvious to choose any of them for their intended purpose with a reasonable expectation of success. For example, while Taylor et al. might teach other organic acids to control the pH that does not make the use of 5-chlrosalicyclic acid for this specific purpose, modifying the pH, any less obvious. Applicants have not demonstrated the unexpectedness of the claimed combination. While Applicants continue to argue that the examples in the instant specification there is not a single exemplified embodiment that contains all the claimed components showing an unexpected effect. Regarding the arguments over the rejection of the claims under 103 over Allef et al. in view of Bernard et al., Moller et al. and Taylor et al. and in further view of Khoshdel et al. Applicants merely reiterate all the arguments previously made. Since those arguments were not persuasive for the reasons set forth above, repeating the arguments again does not change the fact that they are unpersuasive. Double Patenting The nonstatutory double patenting rejection is based on a judicially created doctrine grounded in public policy (a policy reflected in the statute) so as to prevent the unjustified or improper timewise extension of the “right to exclude” granted by a patent and to prevent possible harassment by multiple assignees. A nonstatutory double patenting rejection is appropriate where the conflicting claims are not identical, but at least one examined application claim is not patentably distinct from the reference claim(s) because the examined application claim is either anticipated by, or would have been obvious over, the reference claim(s). See, e.g., In re Berg, 140 F.3d 1428, 46 USPQ2d 1226 (Fed. Cir. 1998); In re Goodman, 11 F.3d 1046, 29 USPQ2d 2010 (Fed. Cir. 1993); In re Longi, 759 F.2d 887, 225 USPQ 645 (Fed. Cir. 1985); In re Van Ornum, 686 F.2d 937, 214 USPQ 761 (CCPA 1982); In re Vogel, 422 F.2d 438, 164 USPQ 619 (CCPA 1970); In re Thorington, 418 F.2d 528, 163 USPQ 644 (CCPA 1969). A timely filed terminal disclaimer in compliance with 37 CFR 1.321(c) or 1.321(d) may be used to overcome an actual or provisional rejection based on nonstatutory double patenting provided the reference application or patent either is shown to be commonly owned with the examined application, or claims an invention made as a result of activities undertaken within the scope of a joint research agreement. See MPEP § 717.02 for applications subject to examination under the first inventor to file provisions of the AIA as explained in MPEP § 2159. See MPEP §§ 706.02(l)(1) - 706.02(l)(3) for applications not subject to examination under the first inventor to file provisions of the AIA . A terminal disclaimer must be signed in compliance with 37 CFR 1.321(b). The USPTO Internet website contains terminal disclaimer forms which may be used. Please visit www.uspto.gov/patent/patents-forms. The filing date of the application in which the form is filed determines what form (e.g., PTO/SB/25, PTO/SB/26, PTO/AIA /25, or PTO/AIA /26) should be used. A web-based eTerminal Disclaimer may be filled out completely online using web-screens. An eTerminal Disclaimer that meets all requirements is auto-processed and approved immediately upon submission. For more information about eTerminal Disclaimers, refer to www.uspto.gov/patents/process/file/efs/guidance/eTD-info-I.jsp. Claims 1-3, 12, 15-18 and 22 are rejected on the ground of nonstatutory double patenting as being unpatentable over claims 1-31 of US Patent No. 10561591 (copending Application No. 15367363 (USPGPUB No. 20170157011)). Although the conflicting claims are not identical, they are not patentably distinct from each other because both sets of claims overlap in scope. It is noted that a notice of allowance has been mailed in this case but no patent number has been issued yet. The instant application claims a shampoo composition comprising from about 0.2 to about 8% of a moisture control material which is oleic acid wherein the shampoo composition further comprises from about 0.5 to about 2% of salicylic acid, from about 2 to about 10% of 2-hydroxyethyl urea and propylene glycol and wherein there is a decrease moisture pickup determined by a DVS method as compared to a control with no moisture control materials and further comprising 5-chlorosalicylic acid and 2-hexyl-1-decanol. The instant application claims method of treating hair using the shampoo composition of Claim 1 wherein hair treated with the shampoo composition results in a decrease moisture pickup determined by a DVS method as compared to a control with no moisture control materials. Patent ‘591 claims a method for hair frizz reduction comprising the steps of a) performing a hair cleansing by applying a hair shampoo and rinsing and b) performing one or more additional hair treatments wherein compositions used in steps a and b) comprise from 0.1 to about 20% of one or more moisture control material. The same moisture control material is claimed. Components specifically claimed include 2-hexyl-1-decanol, 2,4-dihydroxybenzoic acid and 5-chlorosalicylic acid. Salicylic acid is claimed. Hydroxyethyl urea is claimed. Hair treated with the method for hair frizz reduction absorbs moisture at least 2% less than hair treated with the corresponding combination of treatments having no moisture control material, wherein the moisture absorption is measured using DVS method Therefore, the scopes of the patent claims and the instant application overlap and thus they are obvious variants of one another. Claims 1-3, 12, 15-18 and 22 are rejected on the ground of nonstatutory double patenting as being unpatentable over claims 1-28 of US Patent No. 10632054 (Application No. 14677636 (USPGPUB No. 20160287495) in view of Bernard et al. Although the conflicting claims are not identical, they are not patentably distinct from each other because both sets of claims overlap in scope. The instant claims are set forth above. Patent ‘054 claims a method for hair frizz reduction wherein hair is soaked in an aqueous composition comprising a moisture control material. The same moisture control material. Also claimed is 2-hexyl-1-decanol, oleic acid, 2,4-dihydroxybenzoic acid and 5-chlorosalicylic acid. Overlapping pH is claimed. Salicylic acid is claimed. Copending ‘636 does not claim the inclusion of 2-hydroxyethyl urea. However, this deficiency is cured by Bernard et al. Bernard et al. is directed to urea compounds that promote desquamation. Taught is a method for stimulating desquamation of the skin and/or the mucous membranes and/or superficial body growths comprising apply to skin or superficial body growths urea compounds of formula I (claim 1). Claim 6 recites a compound of formula I is N-(2-hydroxyethyl)urea. Application to the skin and/or scalp is claimed (claim 12). Taught is combination of two desquamation-stimulating agents the compound of formula I and salicylic acid (paragraph 0223). The quantity of N-(2-hydroxyethyl)urea and of any other compound of formula I is from 0.1 to 20% by weight. Less than or equal to 10% by weight is particular for daily care applications (paragraph 0038). Compositions taught include shampoos (paragraph 0073). It would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to combine the teachings of patent ‘054 and Bernard et al. and utilize 2-hydroxyethyl urea in the composition of patent ‘054 in order to provide for desquamation as taught by Bernard et al. With regard to the functional limitation pertaining to decrease in moisture pickup, patent ‘054 discloses the same claimed moisture control materials. Note MPEP 2112.01: "Products of identical chemical composition cannot have mutually exclusive properties." A chemical composition and its properties are inseparable. Therefore, if the prior art teaches the identical chemical structure, the properties applicant discloses and/or claims are necessarily present. In re Spada, 911 F.2d 705,709, 15 USPQ2d 1655, 1658 (Fed. Cir. 1990). Claims 1-3, 12, 15-18 and 22 are rejected on the ground of nonstatutory double patenting as being unpatentable over claims 1-18 of US Patent No. 10111820 (Application No. 14959243; USPGPUB No. 20160158135). Although the conflicting claims are not identical, they are not patentably distinct from each other because both sets of claims overlap in scope. The instant claims are set forth above. Patent ‘820 claims a rinse-off condition composition for hair frizz reduction comprising about 0.2 to about 20% of a moisture control material. The same moisture control material is claimed. Also claimed is 5-chlorosalicylic acid, 2-hexyl-1-decanol, 2-4-dihydroxybenzoic acid and oleic acid. Overlapping pH is claimed. Cationic surfactant and high melting point fatty compounds are claimed. Solvents are claimed. Salicylic acid is claimed. Hydroxyethyl urea is claimed. With regard to the functional limitation pertaining to decrease in moisture pickup, patent ‘820 discloses the same claimed moisture control materials. Note MPEP 2112.01: "Products of identical chemical composition cannot have mutually exclusive properties." A chemical composition and its properties are inseparable. Therefore, if the prior art teaches the identical chemical structure, the properties applicant discloses and/or claims are necessarily present. In re Spada, 911 F.2d 705,709, 15 USPQ2d 1655, 1658 (Fed. Cir. 1990). Therefore, the scopes of the copending claims and the instant application overlap and thus they are obvious variants of one another. Claims 1-3, 12, 15-18 and 22 are rejected on the ground of nonstatutory double patenting as being unpatentable over claims 1-15 of US Patent No. 10111815 (Application No. 14742136) in view of Allef et al. as evidenced by Benvenuti. Although the conflicting claims are not identical, they are not patentably distinct from each other because both sets of claims overlap in scope. The instant claims are set forth above. Patent ‘815 claims an aqueous hair leave-on composition for hair frizz reduction comprising: from about 0.15% to about 12% of a moisture control material or mixture of moisture control materials, wherein the moisture control material comprises salicylic acid in combination 2,4-dihydroxybenzoic acid, and wherein the leave-on composition further comprises a material selected from the group consisting of glycols, polyglycols, 2-hydroxyethyl urea and mixture thereof. 5-chlorosalicylic acid is claimed. 2-hydroxyethyl urea in an amount from 0.2 to 10% is specifically claimed. A pH from 2 to 7 is claimed. The same further materials are claimed. Cationic surfactant system is claimed. Fatty compounds are claimed. Patent ‘815 does not expressly claim oleic acid. However, this deficiency is cured by Allef et al. Allef et al. is directed to aqueous hair and skin cleaning compositions comprising biosurfactants. Table 24 is a shampoo comprising water (solvent) in an amount greater than 20%, oleic acid in 0.4%, cocamidopropyl betaine (cationic surfactant in 2% reading on instant claim 18), propylene glycol and citric acid to adjust pH to 5.0 (reading on instant claims 15-16). Table 25 teaches a shampoo comprising water in greater than 20%, oleic acid in 0.15%, propylene glycol, glycol distearate in 1% and cocamidopropyl betaine in 2.5 (reading on cationic surfactant of claim 18). Gels are taught (claim 15). The fatty acid is included in amounts from 0.1 to 20% by weight of the sum of fatty acid and surfactants where surfactants are used in an amounts from 1 to 30% (claim 1). Fatty acids taught include valeric acid and oleic acid (paragraph 0029). Exemplified compositions include oleic acid and salicylic acid and propylene glycol (table 41, 66, 77, 82, reading on the claimed combination of oleic acid, salicylic acid and propylene glycol recited in claim 1). Exemplified amounts of salicylic acid include 2% (table 66). The compositions can also comprise urea (paragraph 0046). Benvenuti teaches that Pequi oil which is mostly oleic acid is better for frizzy hair. It would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to combine the teachings of patent ‘815 and Allef et al. and utilize oleic acid in the composition of patent ‘815. One skilled in the art would have been motivated to add oleic acid as it is a fatty compound which is better for frizzy hair. Since patent ‘815 claims fatty compounds can be included and the composition is for hair frizz reduction there is a reasonable expectation of success. Allef et al. teaches amounts of oleic acid which read on the instant claims. Claims 1-3, 12, 15-18 and 22 are rejected on the ground of nonstatutory double patenting as being unpatentable over claims 1-16 of US Patent No. 10117819 (Application No. 14959234) in view of Allef et al. as evidenced by Benvenuti. Although the conflicting claims are not identical, they are not patentably distinct from each other because both sets of claims overlap in scope. The instant claims are set forth above. Patent ‘819 claims a rinse-off conditioner composition for hair frizz reduction comprising: from about 0.2% to about 20% of a moisture control material or mixture of moisture control materials, wherein the moisture control material comprises salicylic acid in combination 2,4-dihydroxybenzoic acid, and wherein the rinse-off conditioner composition further comprises a material selected from the group consisting of glycols, polyglycols, 2-hydroxyethyl urea and mixture thereof. 5-chlorosalicylic acid is claimed. 2-hydroxyethyl urea in an amount from 0.2 to about 10% is claimed. pH of 2 to 5 is claimed. Same additional components are claimed. A cationic surfactant system is claimed. Fatty compounds are claimed. Patent ‘819 does not expressly claim oleic acid. However, this deficiency is cured by Allef et al. The teachings of Allef et al. are set forth above. It would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to combine the teachings of patent ‘819 and Allef et al. and utilize oleic acid in the composition of patent ‘819. One skilled in the art would have been motivated to add oleic acid as it is a fatty compound which is better for frizzy hair. Since patent ‘819 claims fatty compounds can be included and the composition is for hair frizz reduction there is a reasonable expectation of success. Allef et al. teaches amounts of oleic acid which read on the instant claims. Claims 1-3, 12, 15-18 and 22 are rejected on the ground of nonstatutory double patenting as being unpatentable over claims 1-16 of US Patent No. 10258555 (Application No. 15367369) in view of Allef et al. as evidenced by Benvenuti. Although the conflicting claims are not identical, they are not patentably distinct from each other because both sets of claims overlap in scope. The instant claims are set forth above. Patent ‘555 claims a shampoo composition for hair frizz reduction comprising: from about 0.1% to about 20% of a moisture control material or mixture of moisture control materials wherein the moisture control material comprises salicylic acid in combination with 2,4-dihydroxybenzoic acid wherein shampoo composition further comprises a material selected from the group consisting of glycols, polyglycol and 2-hydroxyethyl urea or mixture thereof. 5-chlrosaliylic acid is claimed. A pH from about 3 to about 5.5 is claimed. The same additional components are claimed. 2-hydroxyethyl urea in an amount from 0.2 to 10% is claimed. Cationic surfactant system is claimed. Patent ‘555 does not expressly claim oleic acid. However, this deficiency is cured by Allef et al. The teachings of Allef et al. are set forth above. It would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to combine the teachings of patent ‘555 and Allef et al. and utilize oleic acid in the composition of patent ‘555. One skilled in the art would have been motivated to add oleic acid as it is a fatty compound which is better for frizzy hair. Since patent ‘555 claims fatty compounds can be included and the composition is for hair frizz reduction there is a reasonable expectation of success. Allef et al. teaches amounts of oleic acid which read on the instant claims. Response to Arguments Applicants’ arguments filed June 14 2024 have been fully considered but they are not persuasive. Applicants argue that the NSDP rejections should be held in abeyance. Regarding applicants’ argument, the rejections are maintained since applicant has not made any substantive arguments traversing the rejection. .Applicant(s) is/are reminded that a request to hold a rejection in abeyance is not a proper response to a rejection. Rather, a request to hold a matter in abeyance may only be made in response to an OBJECTION or REQUIREMENTS AS TO FORM (see MPEP 37 CFR 1.111(b) and 714.02). Conclusion THIS ACTION IS MADE FINAL. Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any extension fee pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action. Any inquiry concerning this communication or earlier communications from the examiner should be directed to ABIGAIL VANHORN whose telephone number is (571)270-3502. The examiner can normally be reached M-Th 6 am-4 pm EST. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Scarlett Y Goon can be reached on 571-270-5241. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /ABIGAIL VANHORN/ Primary Examiner, Art Unit 1616
Read full office action

Prosecution Timeline

Show 36 earlier events
Feb 23, 2025
Response after Non-Final Action
May 28, 2025
Response after Non-Final Action
May 29, 2025
Response after Non-Final Action
May 29, 2025
Response after Non-Final Action
Feb 04, 2026
Response after Non-Final Action
Jun 22, 2026
Request for Continued Examination
Aug 26, 2026
Response after Non-Final Action
Sep 30, 2026
Non-Final Rejection mailed — §103, §DOUBLEPATENT (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12742162
Conjugates of Guide RNA-Cas Protein Complex
6y 1m to grant Granted Sep 22, 2026
Patent 12735702
ENDOSOMAL CLEAVABLE LINKERS
4y 7m to grant Granted Sep 15, 2026
Patent 12685766
MODIFIED GENE VACCINES AGAINST AVIAN CORONAVIRUSES AND METHODS OF USING THE SAME
3y 8m to grant Granted Jul 21, 2026
Patent 12678400
IMPLANTABLE DEVICES FOR DRUG DELIVERY WITH REDUCED BURST RELEASE
3y 7m to grant Granted Jul 14, 2026
Patent 12678401
IMPLANTABLE DEVICES FOR DRUG DELIVERY WITH REDUCED BURST RELEASE
3y 2m to grant Granted Jul 14, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

11-12
Expected OA Rounds
47%
Grant Probability
69%
With Interview (+22.4%)
3y 9m (~0m remaining)
Median Time to Grant
High
PTA Risk
Based on 1219 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month